Product
scAAV2-P1ND4v2
1 clinical trial
1 indication
Indication
Leber's Hereditary Optic NeuropathyClinical trial
An Open-label Dose Escalation Study of an Adeno-associated Virus Vector (scAAV2-P1ND4v2) for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation in Mitochondrial DNAStatus: Active (not recruiting), Estimated PCD: 2023-03-31